Literature DB >> 20685361

Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury.

Anna Erlandsson1, Chia-Hsun Anthony Lin, Fenggang Yu, Cindi M Morshead.   

Abstract

Recent work has demonstrated that self-repair in the adult brain can be augmented by the infusion of growth factors to activate endogenous neural precursor cells that contribute to new tissue formation and functional recovery in a model of stroke. Using both a genetic model and drug treatment, we demonstrate that immunosuppression mimics the effects of growth factor activation, including tissue regeneration, neural precursor cell migration and functional recovery following ischemic injury. In the absence of growth factor treatment, mice with a functional immune system develop a prominent cavity in the cortex underlying the ischemic injury. In untreated immunodeficient NOD/SCID mice, however, the cortical cavity forms but is then filled with regenerated cortical tissue containing glial cells and subependyma derived neural stem and progenitor cells that migrate from their niche lining the lateral ventricles. The daily administration of Cyclosporine A also results in endogenous neural precursor cell migration and regenerated cortical tissue at the site of the cortical injury. Different from growth factor-treated animals is the finding that the regenerated cortical tissue in immunosuppressed animals is devoid of new neurons. Interestingly, both the growth factor and immunosuppressed (NOD/SCID and Cyclosporine A) treated animals displayed functional behavioural recovery despite the lack of neurogenesis within the regenerated cortical tissue. This article is part of a Special Issue entitled "Interaction between repair, disease, & inflammation."
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685361     DOI: 10.1016/j.expneurol.2010.05.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  29 in total

Review 1.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

Review 2.  Effects of inflammation on stem cells: together they strive?

Authors:  Caghan Kizil; Nikos Kyritsis; Michael Brand
Journal:  EMBO Rep       Date:  2015-03-04       Impact factor: 8.807

Review 3.  Role of neural precursor cells in promoting repair following stroke.

Authors:  Pooya Dibajnia; Cindi M Morshead
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

Review 4.  Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.

Authors:  Ania Dabrowski; Thomas J Robinson; Ryan J Felling
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-02       Impact factor: 5.081

5.  Monocyte-Derived Macrophages Modulate Inflammation and Promote Long-Term Functional Recovery in a Mouse Model of Ischemia.

Authors:  Adam Kovacs-Litman; Ilan Vonderwalde
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167

Review 6.  Targeted delivery of nano-therapeutics for major disorders of the central nervous system.

Authors:  Huile Gao; Zhiqing Pang; Xinguo Jiang
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

Review 7.  Stem cells and stroke: opportunities, challenges and strategies.

Authors:  Terry C Burns; Gary K Steinberg
Journal:  Expert Opin Biol Ther       Date:  2011-02-16       Impact factor: 4.388

Review 8.  Neurorestoration after stroke.

Authors:  Tej D Azad; Anand Veeravagu; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2016-05       Impact factor: 4.047

9.  Effects of adult neural precursor-derived myelination on axonal function in the perinatal congenitally dysmyelinated brain: optimizing time of intervention, developing accurate prediction models, and enhancing performance.

Authors:  Crystal A Ruff; Hui Ye; Jean M Legasto; Natasha A Stribbell; Jian Wang; Liang Zhang; Michael G Fehlings
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

Review 10.  Cell-based therapy for ischemic stroke.

Authors:  Jing Zhang; Michael Chopp
Journal:  Expert Opin Biol Ther       Date:  2013-06-06       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.